Chimerix, Inc. CMRX
8.54 0.00 (+0.00%)
At closeApr 21, 2025, 4:00 PM EDT
8.54 Day range 8.54
52-week range unavailable
- YTD
- +145.40%
- 1 year
- +844.69%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 8.40 -1.6% downside
Now 8.54
- Target (low)
- 6.00
- Target (mean)
- 8.40
- Target (high)
- 11.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy1
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.275 | -0.31 – -0.24 | -0.20 | -37.5% | 310.60K | +7665.0% | 2 |
| Next quarter | -0.29 | -0.29 – -0.29 | -0.25 | -16.0% | 100.00K | 0.0% | 1 |
| Current year | -1.01 | -1.03 – -0.98 | -0.93 | -8.1% | 937.80K | +189.4% | 2 |
| Next year | -1.11 | -1.26 – -0.95 | -1.01 | -10.0% | 4.12M | +339.1% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 18, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Nov 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 17, 2023 | Wedbush | Reiterated | Outperform | Outperform |
| Aug 16, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 4, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 23, 2023 | Baird | Initiated | — | Outperform |
| May 5, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 3, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Sep 7, 2022 | Capital One | Initiated | — | Overweight |
| May 17, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Dec 22, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 22, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Jun 7, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| May 6, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Apr 29, 2021 | Maxim Group | Initiated | — | Buy |
| Mar 31, 2021 | Wedbush | Initiated | — | Outperform |
| Mar 31, 2021 | Jefferies | Initiated | — | Buy |
| Jan 11, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 6, 2019 | Citigroup | Maintained | Neutral | Neutral |
| Feb 14, 2018 | JP Morgan | Downgrade | Neutral | Underweight |
| Feb 2, 2018 | HC Wainwright & Co. | Initiated | — | Buy |
| Feb 23, 2016 | Barclays | Downgrade | Overweight | Equal-Weight |
| Feb 22, 2016 | Morgan Stanley | Downgrade | Equal-Weight | Underweight |
| Feb 22, 2016 | Citigroup | Downgrade | Buy | Neutral |
| Dec 29, 2015 | Morgan Stanley | Maintained | — | Equal-Weight |
| Dec 29, 2015 | FBR Capital | Downgrade | Outperform | Market Perform |
| Dec 29, 2015 | JP Morgan | Downgrade | Overweight | Neutral |